Siobhan Loughna
Associate Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
About
Siobhan Loughna is an Associate Professor at the Faculty of Medicine and Health Sciences, University of Nottingham, located in Nottingham, UK. Her research primarily focuses on cardiovascular development and disease, with recent articles investigating the role of cyclin-dependent kinase 13, the implications of α-actinin isoforms, and the effects of PRKD1 deletion in mouse heart development. She also engages in functional analysis through RNA sequencing in models of pressure overload in developing hearts.
Articles (6)
Year:
2026
Year:
2025
Year:
2025
Year:
2025
Congenital heart disease (CHD) is the most common congenital anomaly, with an overall incidence of approximately 1% in the United Kingdom. Exome sequencing in large CHD cohorts has been performed to provide insights into the genetic aetiology of CHD. This includes a study of 1891 probands by our group in collaboration with others, which identified three novel genes— CDK13, PRKD1 , and CHD4 , in patients with syndromic CHD. PRKD1 encodes a serine/threonine protein kinase, which is important in a variety of fundamental cellular functions. Individuals with a heterozygous mutation in PRKD1 may have facial dysmorphism, ectodermal dysplasia and may have CHDs such as pulmonary stenosis, atrioventricular septal defects, coarctation of the aorta and bicuspid aortic valve. To obtain a greater appreciation for the role that this essential protein kinase plays in cardiogenesis and CHD, we have analysed a Prkd1 transgenic mouse model ( Prkd1 em1 ) carrying deletion of exon 2, causing loss of function. High‐resolution episcopic microscopy affords detailed morphological 3D analysis of the developing heart and provides evidence for an essential role of Prkd1 in both normal cardiac development and CHD. We show that homozygous deletion of Prkd1 is associated with complex forms of CHD such as atrioventricular septal defects, and bicuspid aortic and pulmonary valves, and is lethal. Even in heterozygotes, cardiac differences occur. However, given that 97% of Prkd1 heterozygous mice display normal heart development, it is likely that one normal allele is sufficient, with the defects seen most likely to represent sporadic events. Moreover, mRNA and protein expression levels were investigated by RT‐qPCR and western immunoblotting, respectively. A significant reduction in Prkd1 mRNA levels was seen in homozygotes, but not heterozygotes, compared to WT littermates. While a trend towards lower PRKD1 protein expression was seen in the heterozygotes, the difference was only significant in the homozygotes. There was no compensation by the related Prkd2 and Prkd3 at transcript level, as evidenced by RT‐qPCR. Overall, we demonstrate a vital role of Prkd1 in heart development and the aetiology of CHD.
Year:
2024
Year:
2020
Collaborators (7)
Neil V. Morgan
University of Birmingham
Marc-Phillip Hitz
Head of Medical Genetics
Carl von Ossietzky Universität Oldenburg
QAZI WAHEED ULLAH
Lecturer
University of Lincoln
Alexandre Slater
Dr at University of Birmingham
University of Birmingham
Maya Noureddine
PhD Research Placement
University of Oxford
Charles Redwood
Assistant Professor
University of Oxford
Nikos Pinotsis
Birkbeck University of London
Make your next move.
Prepare your application
Review drafts before you send them.